The antibacterial agent levofloxacin (Levaquin) has been approved to treat and prevent the plague, the FDA announced. The drug – already approved for a range of indications – got the nod under the FDA’s Animal Efficacy Rule, which allows …
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Top 100 Pharmaceutical Enterprises and the Listed Company SZ.002020